<unk>  is an anti-allergic and anti-asthmatic agent that is FDA approved for the treatment of allergic asthma and chronic idiopathic urticaria. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include arthralgia, pain (general), leg pain, fatigue, dizziness, fracture, arm pain, pruritus, dermatitis, earache, nausea, nasopharyngitis, sinusitis, upper respiratory tract infection, viral upper respiratory tract infection, headache, and cough.
Omalizumab
Reslizumab
Tildrakizumab
Risankizumab
Nebacumab
Dupilumab
Mogamulizumab
Ocrelizumab